Ureaplasma

GeneProof Announces Expansion of its IVDR-Certified PCR Portfolio

Retrieved on: 
Tuesday, October 3, 2023
Ureaplasma urealyticum, CT, IVDR, Urinary tract infection, Workflow, CP, Infection, Neisseria gonorrhoeae, Chlamydia trachomatis, Real-time, Quality management system, Mycoplasma genitalium, Mycoplasma hominis, NG, Canine vector-borne disease, Diagnosis, PCR, Chlamydia pneumoniae, Medical device, Telecommunications, Ureaplasma, EU, Mycoplasma, Chlamydia

BRNO, Czech Republic, Oct. 3, 2023 /PRNewswire/ -- GeneProof, a leader in molecular diagnostics, today announced the addition of six new IVDR-certified PCR kits to its expansive portfolio.

Key Points: 
  • BRNO, Czech Republic, Oct. 3, 2023 /PRNewswire/ -- GeneProof, a leader in molecular diagnostics, today announced the addition of six new IVDR-certified PCR kits to its expansive portfolio.
  • This comes as a testament to the company's dedication to delivering its entire portfolio of approximately 80 products as IVDR compliant by 2027.
  • Currently, 27 products are IVDR cleared, with 16 that are Notified Body certified in class C and B.
  • GeneProof was among the first to obtain the EU Certificate for Quality Management System under the new Regulation (EU) 2017/746 IVDR.

Latin America Vitro Diagnostic (IVD) Tests Market Research Report 2023: Focus on Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela - ResearchAndMarkets.com

Retrieved on: 
Monday, March 27, 2023
Biotechnology, Science, Health, Research, Syphilis, Blood, Interleukin, Autoimmunity, Hormone, Molecular biology, Market, Other Nationalities rugby league team, Histology, Toxicology, Torch, NAT, POC, Leukemia, CT, Pregnancy, Gram, Microbiology, Medium (website), DSM-IV codes, Infection, Flow cytometry, FDP, NG, HPV, BNP, Blood culture, EBV, Allergy, COVID-19, MRSA, Fibrinogen, Hepatitis, AIDS, Hemostasis, Anemia, CMV, IVD, APTT, Glycated hemoglobin, Lymphoma, TSH, Fecal occult blood, HIV, Control, PCT, Thrombosis, MTB, Fertility, Coagulation, Cardiology, LATAM, Drug, Vaccine, Medical imaging, Ureaplasma, Sepsis, Mycoplasma, Myoglobin

The "The Market for In Vitro Diagnostic (IVD) Tests in Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela and Other Nations)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "The Market for In Vitro Diagnostic (IVD) Tests in Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela and Other Nations)" report has been added to ResearchAndMarkets.com's offering.
  • This market report focuses on the market for reagents and instruments in the most important countries of the region.
  • Brazil and Mexico represent the two largest countries in terms of population, accounting for more than half of LATAM total population.
  • For this reason, these two countries have been the focus of many IVD suppliers in recent years.